Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan D Hoban

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Blood|April 8, 2016
A genome editing primer for the hematologistMegan D Hoban, Daniel E Bauer
Blood|January 14, 2016
Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell diseaseMegan D Hoban, Stuart H Orkin, Daniel E Bauer
Current Protocols in Stem Cell Biology|February 4, 2016
Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor CellsMegan D Hoban, Zulema Romero, Gregory J Cost, et al.
Human Gene Therapy|February 27, 2014
Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectorsAlok V Joglekar, Libby Stein, Michelle Ho, et al.
Nature Biotechnology|July 13, 2016
Analyzing CRISPR genome-editing experiments with CRISPRessoLuca Pinello, Matthew C Canver, Megan D Hoban, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 10, 2017
Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor CellsJoseph Long, Megan D Hoban, Aaron R Cooper, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cellsZulema Romero, Beatriz Campo-Fernandez, Jennifer Wherley, et al.
Cell Reports|May 31, 2018
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM SyndromeCaroline Y Kuo, Joseph D Long, Beatriz Campo-Fernandez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 14, 2016
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cellsMegan D Hoban, Dianne Lumaquin, Caroline Y Kuo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2019
Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor TemplatesZulema Romero, Anastasia Lomova, Suzanne Said, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood|April 8, 2016
A genome editing primer for the hematologistMegan D Hoban, Daniel E Bauer
Blood|January 14, 2016
Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell diseaseMegan D Hoban, Stuart H Orkin, Daniel E Bauer
Current Protocols in Stem Cell Biology|February 4, 2016
Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor CellsMegan D Hoban, Zulema Romero, Gregory J Cost, et al.
Human Gene Therapy|February 27, 2014
Dissecting the mechanism of histone deacetylase inhibitors to enhance the activity of zinc finger nucleases delivered by integrase-defective lentiviral vectorsAlok V Joglekar, Libby Stein, Michelle Ho, et al.
Nature Biotechnology|July 13, 2016
Analyzing CRISPR genome-editing experiments with CRISPRessoLuca Pinello, Matthew C Canver, Megan D Hoban, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 10, 2017
Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor CellsJoseph Long, Megan D Hoban, Aaron R Cooper, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cellsZulema Romero, Beatriz Campo-Fernandez, Jennifer Wherley, et al.
Cell Reports|May 31, 2018
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM SyndromeCaroline Y Kuo, Joseph D Long, Beatriz Campo-Fernandez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 14, 2016
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cellsMegan D Hoban, Dianne Lumaquin, Caroline Y Kuo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2019
Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor TemplatesZulema Romero, Anastasia Lomova, Suzanne Said, et al.
Pageof 2